Limited plasmin proteolysis of vitronectin: Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor

European Journal of Biochemistry

Volumn 236, Issue 2, 1996, Pages 682-688

  Kost, Christine ^a   Benner, Kerstin ^a   Stockmann, Antje ^a   Linder, Dietmar ^b   Preissner, Klaus T ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Adhesion; Angiostatin; Plasmin; Proteolysis; Vitronectin

Indexed keywords

ANGIOSTATIN; HEPARIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VITRONECTIN;

ARTICLE; BINDING SITE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANGIOSTATINS; CELL ADHESION MOLECULES; ENZYME ACTIVATION; HEPARIN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES; PLASMIN; PLASMINOGEN; PROTEIN BINDING; TISSUE PLASMINOGEN ACTIVATOR; VITRONECTIN;

EID: 0029920554     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.0682d.x     Document Type: Article

References (42)

1. Pöllänen, J., Stephens, R. W. & Vaheri, A. (1991) Directed plasminogen activation at the surface of normal and malignant cells, Adv. Cancer Res. 57, 273-328.
2. Blasi, F. (1988) Surface receptors for urokinase plasminogen activators. Fibrinolysis 2, 73-84.
3. Hajjar, K. A., Hamel, N. M., Harpel, P. C. & Nachman, R. L. (1987) Binding of tissue plasminogen activator to cultured human endothelial cells, J. Clin. Invest. 80, 1712-1719.
4. Plow, E. F. & Miles, L. A. (1990) Plasminogen receptors in the mediation of pericellular proteolysis, Cell Differ. Dev. 32, 263-276.
5. Loskutoff, D. J., Sawdey, M. & Mimuro, J. (1989) Type-1 plasminogen-activator inhibitor, Prog. Hemostasis Thromb. 9, 87-115.
6. Declerck, P. J., De Mol, M. Alessi, M.-C., Baudner, S., Paques, E.-P., Preissner, K. T., Müller-Berghaus, G. & Collen, D. (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin), J. Biol. Chem. 263, 15454-15461.
7. Salonen, E.-M., Vaheri, A., Pöllänen, J., Stephens, R., Andreasen, P., Mayer, M. Dano, K., Gailit, J. & Ruoslahti, E. (1989) Interaction of plasminogen-activator inhihitor (PAI-1) with vitronectin, J. Biol. Chem. 264, 6339-6343.
8. Mimuro, J. & Loskutoff, D. J. (1989) Purification of a protein from bovine plasma that binds to type-1 plasminogen-activator inhibitor and prevents its interaction with extracellular matrix - evidence that the protein is vitronectin, J. Biol. Chem. 264, 936-939.
9. Lupu, F., Bergonzelli, G. E., Heim, D. A., Cousin, E., Genton, C. Y., Bachmann, F. & Kruithof, E. K. O. (1993) Localization and production of plasminogen-activator inhibitor-1 in human healthy and atherosclerotic arteries, Arterioscler. Thromb. 13, 1090-1100.
10. Sawa, H., Sobel, B. E. & Fujii, S. (1993) Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen-activator inhibitor type 1 by endothelial injury, Circ. Res. 73, 671-680.
11. Preissner, K. T. (1991) Structure and biological role of vitronectin, Annu. Rev. Cell Biol. 7, 275-310.
12. Sane, D. C., Moser, T. L. & Greenberg, C. S. (1991) Limited proteolysis of vitronectin by plasmin destroys heparin binding activity, Thrombosis Haemostas. 66, 310-314.
13. Chain, D., Kreizman, T., Shapira, H. & Shaltiel, S. (1991) Plasmin cleavage of vitronectin: identification of the site and consequent attentuation in binding plasminogen-activator inhibitor-1, FEBS Lett. 285, 251-256.
14. Kost, C., Stüber, W., Ehrlich, H., Pannekoek, H. & Preissner, K. T. (1992) Mapping of binding sites for heparin, plasminogen-activator inhibitor-1 and plasminogen to vitronectin's heparin binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation, J. Biol. Chem. 267, 12098-12105.
15. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. & Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediatesa the suppression of metastases by a Lewis lung carcinoma, Cell 79, 315-328.
16. Preissner, K. T., Wassmuth, R. & Müller-Berghaus, G. (1985) Physicochemical characterization of human S-protein and its function in the blood coagulation system, Biochem. J. 231, 349-355.
17. Preissner, K. T., Grulich-Henn, J., Ehrlich, H. J., Declerck, P., Justus, C., Collen, D., Pannekoek, H. & Müller-Berghaus, G. (1990) Structural requirements for the extracellular interaction of plasminogen-activator inhibitor 1 with endothelial cell matrix-associated vitronectin, J. Biol. Chem. 265, 18490-18498.
18. Sancho, E., Tonge, D. W., Hockney, R. C. & Booth, N. A. (1994) Purification and characterization of active and stable reccombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coli, Eur. J. Biochem. 224, 125-134.
19. Deutsch, D. G. & Mertz, E. T. (1970) Plasminogen: purification from human plasma by affinity chromatography, Science 170, 1095-1096.
20. Preissner, K. T. (1990) Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator. Biochem. Biophys. Res. Commun. 168, 966-971.
21. Laemmli, U. K. (1970) Cleavage of structure proteins during assembly of the head bacteriophage T4, Nature 227, 680-685.
22. Towbin, H., Staehelin, T. & Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl Acad. Sci. USA 76, 4350-4354.
23. Hayman, E. G., Pierschbacher, M. D., Ohgren, Y. & Ruoslahti, E. (1983) Serum spreading factor (vitronectin) is present at the cell surface and in tissues, Proc. Natl Acad. Sci. USA 80, 4003-4007.
24. Linder, M., Linder, D., Hahnen, J., Schott, H.-H. & Stirm, S. (1992) Localization of the intrachain disulfide bonds of the envelope glycoprotein 71 from Friend murine leukemia virus, Eur. J. Biochem. 203, 65-73.
25. Stockmann, A., Hess, S., Declerck, P., Timpl, R. & Preissner, K. T. (1993) Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein, J. Biol. Chem. 268, 22874-22882.
26. Miles, L. A., Dahlberg, C. M., Plescia, J., Felez, J., Kato, K. & Plow, E. F. (1991) Role of cell-surface lysines in plasminogen binding to cells: identification of α-enolase as a candidate plasminogen receptor, Biochemistry 30, 1682-1691.
27. McKay, T. J., Phelan, A. W. & Plummer, T. H. (1979) Comparative studies on human carboxypeptidases B and N. Arch. Biochem. Biophys. 197, 487-492.
28. Tomasini, B. R. & Mosher, D. F. (1990) Vitronectin, Prog. Hemostasis Thromb. 10, 269-305.
29. Hess, S., Kanse, S. M., Kost, C. & Preissner, K. T. (1995) The versatility of adhesion receptor ligands in haemostasis: morphoregulatory functions of vitronectin, Thrombosis Haemostas. 74, 258-265.
30. Bornstein, P. (1995) Diversity of functions is inherent in matricellular proteins: an appraisal of thrombospondin 1, J. Cell Biol. 130, 503-506.
31. Reinartz, J., Bartla, R., Boukamp, P., Fusenig, N. & Kramer, M. P. (1993) Binding and activation of plasminogen at the surface of keratinocytes, Exp. Cell Res. 208, 197-208.
32. Kramer, M. D., Gissler, H. M., Weidenthaler-Barth, B. & Preissner, K. T. (1993) Vitronectin and plasmin(ogen) in lesional skin of the bullous pemphigoid: colocalisation suggests binding interactions, in Biology of vitronectins and their receptors (Preissner, K. T., Rosenblatt, S., Wegerhoff, J., Kost, C. & Mosher, D. F., eds) pp. 295-301, Elsevier, Amsterdam.
33. Casaroli Marano, R. P., Preissner, K. T. & Vilaro, S. (1995) Fibronectin, laminin, vitronectin and their receptors at newly formed capillaries in proliferative diabetic retinopathy, Exp. Eye Res. 60, 5-17.
34. Tagaki, T. & Doolitlle, R. K (1975) Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments, Biochemistry 14, 940-947.
35. Gechtman, Z., Sharma, R., Kreizman, T., Fridkin, M. & Shaltiel, S. (1993) Synthetic peptides derived from the sequence around the plasma cleavage site in vitronectin. Use in mapping the PAI-1 binding site, FEBS Lett. 315, 293-297.
36. Rijken, D. C., Hoylaerts, M. & Collen, D. (1982) Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator, J. Biol. Chem. 257, 2920-2925.
37. Seiffert, D. & Loskutoff, D. J. (1991) Evidence that type-1 plasminogen-activator inhibitor binds to the somatomedin-B domain of vitronectin, J. Biol. Chem. 266, 2824-2830.
38. Seiffert, D., Ciambrone, G., Wagner, N. V., Binder, B. R. & Loskutoff, D. J. (1994) The somatomedin B domain of vitronectin, J. Biol. Chem. 269, 2659-2666.
39. Lawrence, D. A., Berkenpas, M. B., Palaniappan, S. & Ginsburg, D. (1994) Localization of vitronectin binding domain in plasminogen-activator inhibitor-1, J. Biol. Chem. 269, 15 223-15 228.
40. Aertgeerts, K., De Bondt, H. L., De Ranter, C. & Declerck, P. J. (1994) A model of the reactive form of plasminogen-activator inhibitor-1, J. Struct. Biol. 113, 239-245.
41. Tomasini-Johannson, B., Ruoslahti, E. & Pierschbacher, M. D. (1993) A 30 kD sulfated extracellular matrix protein immunologically crossreactive with vitronectin, Matrix 13, 203-214.
42. s-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin, Exp. Cell Res. 220, 274-282.